Noninvasive colorectal cancer screening test gains FDA approval

Life sciences company Geneoscopy received FDA approval for its noninvasive colorectal cancer screening test, ColoSense.

ColoSense is the first noninvasive colorectal cancer screening test to offer a view of disease activity through RNA biomarkers, according to a May 6 news release from Geneoscopy.

The company is working with payers, professional societies, and advocacy partners to support a commercial launch later this year or early in 2025, according to the release.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Webinars

Featured Whitepapers

Featured Podcast